Glimy MV2 Tablet is used to manage type 2 diabetes in adults by combining three antidiabetic medicines that work through different mechanisms. Voglibose specifically slows carbohydrate absorption in the gut to reduce blood sugar spikes after meals, complementing glimepiride's insulin stimulation and metformin's hepatic glucose reduction.
It contains glimepiride 2mg, metformin, and voglibose 0.2mg. Take it with food as prescribed. The voglibose component works locally in the gut and must be taken with the first bite of each meal for best effect on post-meal glucose. Flatulence and stomach discomfort from voglibose usually reduce over time.
Diet and lifestyle remain important alongside this medicine. Reducing refined carbohydrate intake helps maximise voglibose's post-meal glucose control. Long-term metformin use may reduce vitamin B12 absorption; your doctor may monitor levels periodically.
Before taking this medicine, tell your doctor about any kidney or liver problems, intestinal disorders, or if you drink alcohol regularly. Carry fast-acting glucose (not sucrose) for hypoglycaemia, as voglibose delays complex sugar absorption. Speak to your doctor before use if you are pregnant or breastfeeding.
















































































